United States: New Weapons Against Fraud And Abuse Under The Affordable Care Act
Last Updated: June 25 2012
Article by Joanne B. Erde and Harry R. Silver

Originally published in the South Florida Legal Guide

The individual mandate and the other insurance-related provisions contained in the Affordable Care Act (ACA) have drawn most, if not all, of the public attention. Virtually unnoticed, except by those in the industry, are the significant fraud fighting weapons that the ACA has added to the government's arsenal. These ACA provisions are not under review in the challenges to the act currently before the U.S. Supreme Court. If, however, the entire statute is struck down, it is safe to say that both Republicans and Democrats will be very upset because much of the money that was appropriated by the ACA to implement anti-fraud efforts has already been spent.  More significantly, these ACA provisions are clear money-makers for the government. Should this baby be thrown out with the bathwater of the individual mandate, the government will be deprived of significant fraud fighting tools, as well as a substantial revenue stream.

These fraud fighting provisions in the ACA include the following:

1. Increased Funding to Fight Fraud

The ACA provided mandatory appropriations of $1.7 billion for FY 2010 and $1.7 billion for FY 2011, to fund the fraud enforcement efforts of the Department of Health and Human Services (HHS), the HHS Office of Inspector General (OIG), the Department of Justice (DOJ), and the FBI. The ACA also provided discretionary appropriations of $311 million for FY 2010 and an estimated $561 million for FY 2011.

Much of this funding has already been used.  For example, DOJ's Civil Division has doubled the number of lawyers in its Frauds Section.  In addition, the Centers for Medicare and Medicaid Services (CMS), the agency within HHS that administers Medicare and Medicaid, has established an Office of Program Integrity that has heavily invested in personnel, hardware, software, and programming to verify and crosscheck vast amounts of data. 

These investments have yielded strong returns. On February 14, 2012, DOJ and HHS announced that their joint Fraud and Abuse Control Program, which was utilizing the resources authorized and funded by the ACA, had recovered nearly $4.1 billion in FY 2011.

2. False Claims Act Amendments

The government's weapon of choice against health care fraud has been the federal False Claims Act ("FCA"), because it imposes potentially ruinous civil penalties and because whistleblowers can initiate an action (and receive a percentage of any recovery), thus bringing more instances of alleged fraud to the attention of the government.

The FCA prohibits the submission of false or fraudulent claims, and violations carry civil penalties of $5,500 - $11,000 per claim, plus treble damages.  A large urban hospital can submit hundreds of claims per day to Medicare and Medicaid.  At $5,500 to $11,000 per false claim, potential liability can be in the hundreds of millions of dollars.  Potential liability of this magnitude has proven to be a powerful incentive to settle. The $4.1 billion recovered in FY 2011 is primarily attributable to settlements.

Under the ACA, any person who has received "an overpayment" and fails to report and return it within 60 days of its identification has violated the FCA.  This provision is problematic on many levels.  One area of concern is when does a provider know that it has received an overpayment?  Can a provider identify the overpayment accurately in 60 days? For example, it is not uncommon for a year-end audit to find unidentified revenues on a hospital's books. The determination of the source of these funds, whether they represent an overpayment, if so from whom and how much must be refunded to each payer (private insurance, Medicare, Medicaid), is a labor intensive, time-consuming process that requires more than 60 days. 

Another serious change for providers is the ability of the government or a whistleblower to bring a False Claims Act action for a violation of the Anti-Kickback Statute.  Under the ACA, any claims for items or services resulting from a violation of the Anti-Kickback Statute will constitute false claims for purposes of the FCA.

The ACA also made it easier for a person to initiate a whistleblower action under the FCA, by expanding the pool of individuals who can qualify as an "original source" of the information about the alleged fraud (a prerequisite for bringing a whistleblower suit) and by easing the ban on using publicly disclosed information as the basis for an action.

3. Enhanced Administrative Powers

The ACA authorizes HHS to impose civil monetary penalties on anyone who "knows of an overpayment" and fails to report and return it.  Previously, only those individuals who stood to gain from the overpayment had an obligation to report the overpayment and the government's only remedy was a criminal prosecution. Under the ACA, it is a violation to simply know of an overpayment.  Moreover, the imposition of civil monetary penalties is the result of an administrative proceeding in which the government does not have to meet the higher burden of proof required in a civil or criminal judicial proceeding under the FCA.

The ACA also authorizes HHS to suspend indefinitely all Medicare and Medicaid reimbursement payments to a healthcare provider "pending an investigation of a credible allegation of fraud." A "credible allegation of fraud" includes allegations from any source, even an anonymous source.  Prior notice of a suspension is not required nor is notice of the reason for the suspension.  Providers are not required to be informed of the origin or nature of the allegations of fraud or why they are considered to be credible.

Joanne Erde is a partner in the law firm of Duane Morris LLP. She is a board certified healthcare lawyer. She is admitted to practice in both Florida and New York, and is a member of the American Health Lawyers Association and the Health Law Sections of both the Florida Bar and the New York State Bar Association. Harry Silver is special counsel to Duane Morris LLP based in Washington, D.C.

This article is for general information and does not include full legal analysis of the matters presented. It should not be construed or relied upon as legal advice or legal opinion on any specific facts or circumstances. The description of the results of any specific case or transaction contained herein does not mean or suggest that similar results can or could be obtained in any other matter. Each legal matter should be considered to be unique and subject to varying results. The invitation to contact the authors or attorneys in our firm is not a solicitation to provide professional services and should not be construed as a statement as to any availability to perform legal services in any jurisdiction in which such attorney is not permitted to practice.

Duane Morris LLP, a full-service law firm with more than 700 attorneys in 24 offices in the United States and internationally, offers innovative solutions to the legal and business challenges presented by today's evolving global markets. Duane Morris LLP, a full-service law firm with more than 700 attorneys in 24 offices in the United States and internationally, offers innovative solutions to the legal and business challenges presented by today's evolving global markets. The Duane Morris Institute provides training workshops for HR professionals, in-house counsel, benefits administrators and senior managers.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

More Popular Related Articles on Food, Drugs, Healthcare, Life Sciences from USA
By now you may have heard the news about a number of changes on the horizon for the Health Insurance Portability and Protection Act.
Whether you are an employer that provides health insurance for your employees, a business in the growing healthcare industry, a hospital, or other medical provider—or you provide services to any of those entities—you need to know about changes to the privacy and security rules under the Health Insurance Portability and Accountability Act of 1996 (HIPAA).
A summary of the most recent health care reform implementation updates.
In April 2013, the U.S. Department of Justice announced the settlement of five investigations with healthcare providers.
Understanding the complexities of the Health Insurance Portability and Accountability Act of 1996 (HIPAA) Privacy and Security Rules is often a challenge for health care providers and consumers.
Marilyn Tavenner received bipartisan support from members of the Senate Committee on Finance in her confirmation hearing to lead the Centers for Medicare and Medicaid Services (CMS) though a full Senate vote is being held up, the president released his FY 2014 budget proposal with health care reform and specified reimbursement reductions to providers and manufacturers totaling $400 billion over 10 years sprinkled throughout it, and Department of Health and Human Services (HHS) Secretary Sebelius
The Office of Inspector General for the Department of Health and Human Services has recently issued an updated Special Advisory Bulletin on the Effect of Exclusion from Participation in Federal Health Care Programs.
On Tuesday, the North Carolina legislature has enacted into law, pending the governor's signature, a prohibition on the use of most favored nations clauses in contracts between commercial health insurers and providers.
 
In association with
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert
Email Address
Company Name
Password
Confirm Password
Mondaq Topics -- Select your Interests
Accounting and Audit
Anti-trust/Competition Law
Consumer Protection
Corporate/Commercial Law
Criminal Law
Employment and HR
Energy and Natural Resources
Environment
Family and Matrimonial
Finance and Banking
Food, Drugs, Healthcare, Life Sciences
Government, Public Sector
Immigration
Insolvency/Bankruptcy, Re-structuring
Insurance
Intellectual Property
International Law
Litigation, Mediation & Arbitration
Media, Telecoms, IT, Entertainment
Privacy
Real Estate and Construction
Strategy
Tax
Transport
Wealth Management
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.